← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

A

$ Value

$0

Shares

17,126

Price

$0

Filed

Feb 17

Insider

Name

Kunkel Lori Anne

Title

CIK

0001536368

Roles

Director

Transaction Details

Transaction Date

2026-02-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,126

Footnotes

100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2026 annual meeting of the Issuer's stockholders or (ii) the date of the 2027 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.

Filing Info

Accession No.

0001536368-26-000003

Form Type

4

Issuer CIK

0001672619

Kunkel Lori Anne's History

Date Ticker Type Value
2026-02-12 ELVN A $0
2026-01-02 ORIC A $0
2025-12-17 ELVN M $18K
2025-12-17 ELVN M $0
2025-12-08 ORIC M $79K
2025-12-08 ORIC M $0
2025-12-04 ORIC M $21K
2025-12-04 ORIC M $0
2025-05-19 NRIX A $0

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.0M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12